T. Wasserman

A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02).

E. Shaw, A. Cmelak, J. Loeffler, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Diagnosis and management of plasmacytomas.

T. Wasserman, 1987, Oncology.